PTAC/CFTR
David Bedwell
Biochemistry & Molecular Genetics
Departments of Biochemistry & Molecular Genetics, University of Alabama at Birmingham (UAB), Birmingham, AL
Michelle Hastings, PhD (she/her/hers)
Center for Genetic Diseases
University of Michigan
This session is comprised of a series of short presentations on research investigating approaches for treating cystic fibrosis caused by sequence variants that cause premature translational stop/termination codons (PTCs). The five talks will cover topics from pharmacological rescue of CFTR function that is disrupted by premature termination as well as enhancement of translational readthrough that occurs during inflammation or through the use of antisense oligonucleotide targeting. The consequences of translating through PTCs both on the CFTR function and on cellular processes are also presented.
Speaker: Emily Bulik-Sullivan, n/a (she/her/hers) – UNC-Chapel Hill
Speaker: Jae seok Yoon, PhD (he/him/his) – Cystic Fibrosis Foundation
Speaker: Anna Borrelli, N/A (she/her/hers) – TIGEM- Telethon Institute of Genetics and Medicine
Speaker: Kari Thrasher, PhD – University of Alabama at Birmingham
Speaker: Zhongyou Li, PhD (he/him/his) – University of Colorado Anschutz Medical Campus